Investigators studied the safety and efficacy of zuranolone, a neuroactive steroid γ-aminobutyric acid receptor-positive allosteric modulator, for women with postpartum depression.
Anxiety and depression in people with hyperparathyroidism may be related to levels of 2 key hormones in the body, according to researchers.
Researchers performed a secondary analysis of the AFFINITY trial that assessed the effects of fluoxetine treatment on depression symptoms in patients who recently had a stroke.
Depression in multiple sclerosis (MS) may increase the risks for incident vascular disease and mortality, and the effects of depression and MS on all-cause mortality appear to be synergistic.
The incidence of opioid-associated cardiac arrest increased significantly from 2012 to 2018, according to a study presented at the European Society of Cardiology Congress 2021: The Digital Experience.
Investigators assessed the association between functional gastrointestinal disorders in infants and psychological factors in their mothers.
Severe atopic dermatitis is associated with symptoms of depression and internalizing behaviors throughout childhood.
We examine a pair of recent studies focusing on primary care physicians and what they need to provide better service to patients struggling with their mental health. How can these physicians improve their suicide prevention tools?
An editorial published in the Journal of Sleep Research highlighted recent findings on sleep disturbances in the ICU, the impact shift-scheduling rules have on shift workers’ sleep, and the link between prenatal maternal sleep, long-term anxiety, and depression.
About 20 percent of older adults reported worsening in their mental health since the start of the pandemic.